Operating Partner/Chairman & CEO
Kevin Hykes is a Operating Partner at Versant Ventures and Chairman and CEO of Metavention, Inc., a clinical-stage medical device company focused on the development of interventional therapies for the treatment of type 2 diabetes. Kevin was previously President and CEO of Cameron Health, developer of the first and only subcutaneous implantable defibrillator, until its acquisition by Boston Scientific in 2012. Prior to Cameron Health, he was the Chief Commercial Officer of Visiogen, Inc., a venture-backed ophthalmology company which was acquired by Abbott Medical Optics in 2009. Previous to Visiogen, he spent sixteen years at Medtronic, where he held leadership positions in the CRM, Neurological, Heart Valve, and Cardiac Surgery businesses in the US and Europe. Kevin received his MBA from Northwestern University and a BBA from the University of Wisconsin, and is currently on the boards of Veran Medical Technologies and the Courage Kenny Rehabilitation Institute Foundation.